← Back to Influence Map
Entity DossierOrganization
INCYTE CORPORATION
DE · US
Biopharmaceutical company.
Tracked direct giving
$0
Tracked donations to candidate
$0
LDA reported lobbying spend
$4,650,000
Connections
6
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$9.0MHCRHealth Issues
$1.8MPHAPharmacy
$240KINSInsurance
$120KNATNatural Resources
$120KHOMHousing
$60KGOVGovernment Issues
$60KLobbying Firms Retained
INCYTE CORPORATION$5.9M
TIBER CREEK GROUP$950K
W STRATEGIES, LLC$840K
AVENUE SOLUTIONS$840K
CHECKMATE GOVERNMENT RELATIONS$290K
LMH STRATEGIC SOLUTIONS$240K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | TIBER CREEK GROUP | Hired TIBER CREEK GROUP to lobby on Pharmaceuticals | Source |
| commented_on | Centers for Medicare & Medicaid Services | Public comment on CMS-2025-1889: Global Benchmark for Efficient Drug Pricing Model | Source |
| Employed by | AVENUE SOLUTIONS | Hired AVENUE SOLUTIONS to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | W STRATEGIES, LLC | Hired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |
| Employed by | LMH STRATEGIC SOLUTIONS | Hired LMH STRATEGIC SOLUTIONS to lobby (3rd Quarter (July 1 - Sep 30) 2025) | Source |
| Employed by | CHECKMATE GOVERNMENT RELATIONS | Hired CHECKMATE GOVERNMENT RELATIONS to lobby (4th Quarter (Oct 1 - Dec 31) 2025) | Source |